Cost burden of non-specific chest pain admissions.

Irish Journal of Medical Science
J GroarkeA O Maree

Abstract

Non-cardiac aetiologies are common among patients presenting with chest pain. To determine the cost of non-specific chest pain admissions to a tertiary referral, teaching hospital. Thrombolysis in myocardial infarction risk (TIMI) risk score, lengths of stay (LOS), investigations and diagnoses were recorded for patients admitted with chest pain. Non-specific chest pain was defined as chest pain where cardiac, pulmonary and gastroesophageal aetiologies were excluded. Costs of admissions were calculated. Of 80 patients, 34 (4%) and 22 (28%) were diagnosed with non-specific chest pain and acute coronary syndrome, respectively. Non-specific chest pain admissions had a mean age of 54 (11; 35-74) years, LOS of 3.8 (2.6; 1-11) days and TIMI risk score of 1.4 (1.5; 0-5). Acute coronary syndrome admissions had a mean age of 67 (14; 43-94) years, LOS of 7.7 (4.3; 2-16) days and TIMI risk score of 3.1 (1.2; 0-5). The mean cost per non-specific chest pain admission was €3,729 (2,378; 1,034-10,468), or 48% of the mean cost per acute coronary syndrome admission of €7,667 (4,279; 1,963-16,071). Bed day costs account for >90% of overall costs. Only 7% of patients were weekend discharges. The mean interval to exercise stress test was 2.7(1.5; 1...Continue Reading

References

Mar 1, 1997·Journal of the American College of Cardiology·I S NashV Fuster
Jan 20, 1999·Journal of General Internal Medicine·R A KrasuskiK E Fleischmann
Jan 20, 1999·Journal of General Internal Medicine·C Tanio
Apr 20, 2000·The New England Journal of Medicine·J H PopeH P Selker
Apr 28, 2000·Annals of Emergency Medicine·A B Storrow, W B Gibler
Aug 11, 2000·JAMA : the Journal of the American Medical Association·E M AntmanE Braunwald
Jul 9, 2002·Journal of Thrombosis and Thrombolysis·Kirsten E FleischmannThomas H Lee
Aug 5, 2003·The American Journal of Emergency Medicine·Grace Wu ChanJudd E Hollander
Jan 20, 2005·Heart·S GoodacreJ Nicholl
Apr 3, 2007·Southern Medical Journal·Beril Cakir, Kay Blue
Sep 20, 2007·BMJ : British Medical Journal·Steve GoodacreUNKNOWN ESCAPE Research Team

❮ Previous
Next ❯

Citations

Oct 11, 2013·BMC Health Services Research·Ghassan MouradTiny Jaarsma
Aug 24, 2013·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·D A L HoffA M Drewes
Jun 13, 2015·BMC Cardiovascular Disorders·Luís LeiteJosé Nascimento Costa
Dec 22, 2017·Emergency Medicine Australasia : EMA·Tessa M PoteznyCampbell H Thompson
Jun 20, 2018·Scandinavian Journal of Pain·Jens Brøndum FrøkjærAsbjørn Mohr Drewes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.